Company: WHWK
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015269
Chunk: 238

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1
Chunk 238
---
 and outstanding as of December 31, 2024 and 2023— — Common stock, $0.0001 par value, 300,000,000 shares authorized; 24,680,708 and 24,554,205 shares issued and outstanding as of December 31, 2024 and 2023, respectively2 2 Additional paid-in capital385,114 374,129 Accumulated other comprehensive income16 27 Accumulated deficit(332,654)(268,963)Total stockholders’ equity52,478 105,195 Total liabilities and stockholders’ equity$70,319 $132,423 

The accompanying notes are an integral part of these consolidated financial statements. 

117

WHITEHAWK THERAPEUTICS, INC.

Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share data and earnings per share amounts)

Year Ended December 31,20242023RevenueProduct sales, net$25,983 $24,354 Total revenue25,983 24,354 Operating expensesSelling, general and administrative36,749 44,549 Research and development 51,030 48,929 Restructuring charges2,638 — Cost of goods sold3,024 2,809 Total operating expenses93,441 96,287 Loss from operations(67,458)(71,933)Other income (expense)Foreign exchange loss(4)(1)Interest income3,925 6,400 Interest expense(154)(231)Total other income (expense), net3,767 6,168 Loss before income tax expense(63,691)(65,765)Income tax expense— — Net loss$(63,691)$(65,765)Other comprehensive loss:Unrealized (loss) income on available-for-sale debt securities(11)142 Comprehensive loss$(63,702)$(65,623)Net loss per share, basic and diluted$(2.36)$(2.44)Weighted average number of common shares outstanding, basic and diluted27,029,942 26,917,967 

The accompanying notes are an integral part of these consolidated financial statements. 

118

WHITEHAWK THERAPEUTICS, INC.

Consolidated Statements of Stockholders’ Equity

(in thousands, including share amounts) 

Stockholders’ EquityCommon StockAdditional Paid-In Capital Accumulated